Peer Reviewed Original Articles Published July 1, 2001 - June 30 ...

By Veronica Wagner,2014-07-16 08:43
11 views 0
Peer Reviewed Original Articles Published July 1, 2001 - June 30 ...


Adam H, Nichol K, Hoban DJ and Zhanel GG. Stability of fluoroquinolone resistance in Streptococcus pneumoniae

    clinical isolates and laboratory-derived mutants. Antimicrobial Agents and Chemotherapy 2004;49:846-848. Alfa MJ, Castillo J. Impact of FDA policy change on the reuse of single-use medical devices in Michigan hospitals. Am J Infect Contr 2004Oct;32(6):337-41.

    Alfa MJ, Nemes R. Manual versus automated methods for cleaning reusable accessory devices used for minimally invasive surgical procedures. J Hosp Infect 2004Sep;58(1):50-8.

    Alfa MJ. The laboratory diagnosis of Haemophilus ducreyi. Can J Infect Dis Med Microbiol 2005; 16(1): 31-34.

    Alimonti JB, Koesters SA, Kimani J, Matu L, Wachihi C, Plummer FA and Fowke KR. CD4+ T cell responses in HIV-

    exposed seronegative subjects are qualitatively distinct from those in HIV-infected individuals. J Infect Diseases. 2005. 191:20-4.

    Ao Z, Fowke KR, Cohen EA, Yao X. Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import. Retrovirology. 2005, 2:62. Ariano RE, Nyhen A, Donnelly JP, Sitar DS, Harding GKM, Zelenitsky SA. Pharmacokinetics and Pharmacodynamics

    of Meropenem in Febrile Neutropenic Patients with Bacteremia. Annals of Pharmacother. 2005; 39:32-38. Artsob H. (2004). Emerging and nonemerging arboviral diseases and the veterinary/public health interface. Can. Vet.

     45: 1021-1022. J.

    Athamna A, Athamna M, Abu-Rashed N, Medlej B, Bast DJ, Rubinstein E. Selection of Bacillus anthracis isolates

    resistant to antibiotics. J Antimicrob Chemother 2004;54:424-8.

    Athamna A, Athamna M, Medlej B, Bast DJ, Rubinstein E. In vitro post-antibiotic effect of fluoroquinolones,

    macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis. J Antimicrob Chemother 2004;53:609-15.

    Athamna A, Athamna M, Nura A, Shlyakov E, Bast DJ, Farrell D, Rubinstein E. Is In Vitro Antibiotic Combination

    More Effective than Single-Drug Therapy against Anthrax? Antimicrob Agents Chemother 2005;494:1323-5. Athamna A, Massalha M, Athamna M, Nura A, Medlej B, Ofek I, Bast D, Rubinstein E. In vitro susceptibility of

    Bacillus anthracis to various antibacterial agents and their time-kill activity J Antimicrob Chemother. 2004 53: 247-251. Aziz S, Tam T, Macey JF, Li Y, Jain S, Boulos D, Zheng H, Winchester B, and Zabchuk P. (2005). Influenza in Canada: 2003-2004 season. Can Commun Dis Rep. 31(1): 1- 17.

    Bai H, J. Yang, H. Hiu, S. Wang, Y. Fan, X. Han, S. Xie and X. Yang. Intranasal inoculation of Chlamydia trachomatis

    mouse pneumonitis agent (MoPn) induces significant neutrophil infiltration which is not efficient in controlling the infection in mice. Immunology, 114:246-254, 2005.

    Bai H, J. Yang, H. Qiu, S. Wang, Y. Fan and X. Yang. Expression of proinflammatory cytokines following chlamydia

    trachomatis lung infection. Immunol. J (Chin). 8:119-124, 2004.

    Bai H, J. Yang, H. Qiu, S. Wang, Y. Fan and X. Yang. Production of MIP-1 and MCP chemotactic cytokines following

    Chlamydia trachomatis lung infection and its relationship with host immune defence. Chin. J. Immunol. 23:110-114


    Bakhanashvili M, Novitsky E, Rubinstein E, Levy I, Rahav G. Excision of Nucleoside Analogs from DNA by p53

    Protein, a Potential Cellular Mechanism of Resistance to Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. Antimicrob Agents Chemother 2005;494:1576-9.

    Ball AP, Bartlett JG, Craig WA, Drusano GL, Felmingham D, Garau JA, Klugman KP, Low DE, Mandell LA, Rubinstein

    E, Tillotson GS. Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC. J Chemother. 2004 Oct; 16(5):419-36. Review.

    Banus HA, van Kranen HJ, Mooi FR, Hoebee B, Nagelkerke NJ, Demant P, Kimman TG. Genetic control of Bordetella

    pertussis infection: identification of susceptibility loci using recombinant congenic strains of mice. Infect Immun. 2005 Feb;73(2):741-7.

Barrau K, Boulamery A, Imbert G, Casalta JP, Habib G, Messana T, Bonnet JL, Rubinstein E, Raoult D. Causative

    organisms of infective endocarditis according to host status Clin Microbiol Infect. 2004;10:302-8. Bast DJ, Athamna A, Duncan CL, de Azavedo JC, Low DE, Rahav G, Farrell D, Rubinstein E. Type II topoisomerase

    mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance. J Antimicrob Chemother 2004 ;54:90-4.

    Bastien N, Anderson K, Hart L, Milley D, Brandt K, Van Caeseele P, Hatchette H, and Li Y. (2005) Human

    Coronavirus NL-63 Infection in Canada. J Infect Dis. 191: 503 - 506.

    Baucheron S., S. Tyler, D. Boyd, M. R. Mulvey, E. Chaslus-Dancla, A. Cloeckaert . 2004. AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104 Antimicrob Agents Chemother. 48:3729-3735.

    Beattie T, Kaul R, Rostron T, Dong T, Easterbrook P, Jaoko W, Kimani J, Plummer F, McMichael A, Rowland-Jones S.

    Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes. AIDS 2004;18(11):1595-8.

    Ben David D, Rahav G & Rubinstein E. Future antibiotics and current practices for treating respiratory tract infections. Europ Respir J 2004.

    Berhane Y, Berry JD, Ranadheera C, Marszal P, Nicolas B, Yuan X, Czub M, Weingartl H.: Production and

    characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus. J Virol Methods. 2005.

    Bernard, K.A. 2005. Corynebacterium species and coryneforms. An update on taxonomy and diseases attributed to these taxa Clin. Microbiol. Newslett. 27:9-18 [invited review].

    Bernstein DI, Aoki FY, Tyring SK, Stanberry LR, St-Pierre C, Shafran SD, Leroux-Roels G, Van Herck K, Bollaerts A and Dubin G for the GlaxoSmithKline Herpes Vaccine Study Group. Safety and immunogenicity of glycoprotein-D-adjuvant genital herpes vaccine. Clin Inf Dis 2005; 40:1271-1281.

    Berry JD, Jones S, Drebot MA, Andonov A, Sabara M, Yuan XY, Weingartl H, Fernando L, Marszal P, Gren J,

    Nicolas B, Andonova M, Ranada F, Gubbins MJ, Ball TB, Kitching P, Li Y, Kabani A, Plummer F. Development and

    immunochemical characterization of neutralizing monoclonal antibodies to the SARS-coronavirus (SARS-hCoV). J Virol Meth 2004;120:87-96.

    Bertelsen MF, Olberg RA, Crawshaw GJ, Dibernardo A, Lindsay LR, Drebot M, Barker IK. (2004). West Nile virus

    infections in the eastern loggerhead shrike (Lanius ludovicianus migrans): pathology, epidemiology, and immunization. J Wildl Dis 40: 538-42.

    Blackwood, KS, TV Burdz, CY Turenne, MS Sharma, AM Kabani and JN Wolfe. 2005. Viability testing of material

    derived from Mycobacterium tuberculosis prior to removal from a containment level III as part of a laboratory risk assessment. BMC Infect. Dis. 5:4.

    Blanchard JF, O’Neil JD, Ramesh BM, Bhattacharjee P, Orchard T, Moses S. Understanding the social and cultural

    context of female sex work in Karnataka, India: implications for HIV prevention. J Infect Dis 2005; 191(Suppl


    Booth S, Bowman C, Baumgartner R, Dolenko B, Sorensen G, Robertson C, Coulthart M, Phillipson C, Somorjai R.

    Molecular classification of scrapie strains in mice using gene expression profiling. Biochemical and Biophysical

    2004;325:1339-45. Research Communications

    Booth S, C. Bowman, R. Baumgartner, G. Sorensen, C. Robertson, M. Coulthart, C. Phillipson and R. L. Somorjai.

    Identification of central nervous system genes involved in the host response to the scrapie agent during clinical and pre-clinical infection. J. Gen. Virol. 85, 3459-3471.

    Booth, T. F., B. Kournikakis, N. Bastien, J. Ho, D. Kobasa, L. Stadnyk, Y. Li, M. Spence, S. Paton, B. Henry, B.

    Mederski, D. White, D. E. Low, A. McGeer, A. Simor, M. Vearncombe, J. Downey, F. B. Jamieson, P. Tang, and F.

    Plummer. 2005. Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J.Infect.Dis. 191, no. 9:1472-1477.

    Boulos D., Goedhuis N.J., Wu J., Baptiste B., Poliquin D., Furseth J., Chan J., Bolesnikov G., Barichello F., Andonov

    A., Giulivi A. (2005) Enhanced surveillance for acute and likely acute hepatitis B in Canada: 1999 to 2002. Canadian Journal of Infectious Diseases and Medical Microbiology, 16 (5), 275-281.

    Bow EJ. Long-term antifungal prophylaxis in high-risk hematopoietic stem cell transplant recipients. Medical Mycology 2005: (43) Suppl 1: S277-S287.

    Bow EJ. Management of the febrile neutropenic cancer patient: lessons from 40 years of study. Clin Microbiol Infect. 2005: (11) Suppl 5:24-29.

    Boyd, D. A., S. Tyler, S. Christianson, A. McGeer, M. P. Muller, B. M. Willey, E. Bryce, M. Gardam, P. Nordmann, M. R.

    Mulvey. and the Canadian Nosocomial Infection Surveillance Program, Health Canada. 2004. Complete Nucleotide Sequence of a 92-kb Plasmid Harboring the Extended Spectrum Beta-Lactamase CTX-M-15 Involved in a Long-term Care Outbreak in Toronto. Antimicrobial Agents and Chemotherapy. 48:3758-3764.

    Boyd, D., P. Kibsey, D. Roscoe, M. R. Mulvey and the Canadian Nosocomial Infection Surveillance Program (CNISP). 2004. Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance; characterization of the vanD5 operon. Journal of Antimicrobial Chemotherapy. 54:680-683.

    Busch MP, Tobler LH, Saldanha J, Caglioti S, Venkatakrishna S, Linnen J, Gallarda Phelps B, Smith R, Drebot M,

    Kleinman SH. (2005). Analytical and clinical sensitivity of first generation West Nile virus screening and confirmation assays. Transfusion 45: 492-499.

    Cahane M, Ben Simon GJ, Barequet IS, Grinbaum A, Diamanstein-Weiss L, Goller O, Rubinstein E, Avni I. Human

    corneal stromal tissue concentration after consecutive doses of topically applied 3.3% vancomycin. Br J Ophthalmol 2004;88:22-4.

    Carletti F, Di Caro A, Calcaterra S, Grolla A, Czub M, Ippolito G, Capobianchi MR, Horejsh D. Rapid, differential

    diagnosis of orthopox- and herpesviruses based upon real-time PCR product melting temperature and restriction enzyme analysis of amplicons. J Virol Methods. 2005;129(1):97-100.

    Carlson, J.H., Hughes, S., Hogan, D., Cieplak,G., Sturdevant, D.E., McClarty, G., Caldwell, H., Belland, R.J. 2004.

    Polymorphisms in the Chlamydia trachomatis Cytotoxin Locus Correlate with Pathological Groups. Infect. Immun. 72:7063-7072

    Carrie AC, Metge C, Collins D, Harding GKM and Zhanel GG. Use of administrative healthcare claims to examine

    the effectiveness of trimethoprim-sulfamethoxazole versus fluoroquinolones in the Treatment of community-acquired pyelonephritis. Journal of Antimicrobial Chemotherapy 2004;53:512-517.

    Carrie AC, Metge C, Collins DM, Harding GKM and Zhanel GG. Predictors of receipt of a fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women in Manitoba Canada. Pharmacoepidemiology and Drug Safety 2004; Feb 10:22-33.

    Castellsague X, Peeling RW, Franceschi S, de Sanjose S, Smith JS, Albero G, et al. for the IARC Multicenter Cervical Cancer Study Group. Chlamydia trachomatis infection in Female Partners of circumcised and Uncircumcised Adult Men. Am J Epidemiol 162:907-16, 2005.

    Chen Z, Mustafa T, Trojanowicz B, Brauckhoff M, Gimm O, Schmutzler C, Kohrle J, Holzhausen HJ, Kehlen A, Klonisch T, Finke R, Dralle H, Hoang-Vu C (2004) CD82, and CD63 in thyroid cancer. Int J Mol Med.,14: 517-27.

    Chernesky MA, Patrick D, Peeling R, eds. Canadian Infectious Disease Society. Canadian laboratory standards for sexually transmitted infections: Best practice guidelines. Can J Infect Dis 16: 2005. Clark CG, Bryden L, Cuff WR, Johnson PL, Jamieson F, Ciebin B, Wang G. 2005. Use of the Oxford multilocus

    sequence typing protocol and sequencing of the flagellin short variable region to characterize isolates from a large oubreak of waterborne Campylobacter sp. strains in Walkerton, Ontario, Canada. J Clin Microbiol 43:2080-2091. Cooper CL, Davis HL, Morris ML, Efler SM, Krieg AM, Li Y, Laframboise C, Adhami Al, Khaliq Y, Seguin I and Cameron

    DW (2004). Safety and immunogenicity of CPG 7909 injection as an adjuvant to fluarix influenza vaccine. Vaccine


    Coulthart MB, Posada D, Crandall KA, Dekaban GA. On the Phylogenetic Placement of Human T Cell Leukemia Virus Type 1 Sequences Associated with an Andean Mummy. Infection, Genetics and Evolution 2006;6:91-6 (published

    . online March 23, 2005)

    Cowan FM, Hargrove J, Langhaug LF, Jaffar S, Mhuriyengwe L, Swarthout TD, Matsikire E, Peelng RW, Latif A,

    Bassett M, Brown DWG, Mabey D, Hayes RJ, Wilson D. The appropriateness of core group interventions using presumptive periodic treatment among rural Zimbabwean women who exchange sex for gifts or money. J. AIDS

    38:202-7, 2005.

Cowan FM, Lanhaug L, Hargrove J, Jaffar S, Mhuriyengwe L, Swarthout TD, Matsikire E, Peeling RW, Latif A, Bassett

    M, Brown DWG, Mabey D, Hayes RJ, Wilson D. Is contact with sex workers important in driving the HIV epidemic in rural Zimbabwe? J. AIDS 40:371-6, 2005.

    Czub M, Weingartl H, Czub S, He R, Jingxin C: Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets. Vaccine. 2005;23(17-18):2273-9.

    Czub Markus, Hana Weingartl, Stephanie Czub, Runtao He, Jingxin Cao (corresponding author). Evaluation of

    modified vaccinia virus Ankara based recombinanr SARS vaccine in ferrets. Vaccine 2005, 23(17-18):2271-2277. Czub, S, Czub, M, Koutsilieri, E, Sopper, S, Villinger, F, Muller, JG, Stahl-Hennig, C, Riederer, P, Ter Meulen, V, Gosztonyi, G.: Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs. Acta Neuropathol

     2004;107(3):216-26. (Berl).

    Daddario KM, Gutieri MC, Mothe BR, Larsen T, Hensley LE, Jahrling PB, Feldmann H (2005). Development of a new

    vaccine for the prevention of Lassa fever. Plos Med. 2: 537-545.